Regulatory & Commercialisation

Nicole Dale

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Digital twins in clinical trials simulate patient outcomes to reduce risk and accelerate timelines. Learn how sponsors use them for predictive trial design.

Nicole Dale

Deep Learning in Clinical Trials for 2026 and Beyond

Pharmatica representation of deep learning in clinical trials, especially AI‑driven patient recruitment in clinical trials with a realistic laboratory setting and data visualisations, global site maps, and trial analytics dashboards illustrating machine learning in clinical trials, patient recruitment AI, and adaptive trial design AI.

Deep learning is changing how clinical trials are designed, run, and analysed in 2026. Examine the tools, outcomes, and strategic risks shaping adoption.

Nicole Dale

Maximise Pharma Innovation With Quality-by-Design

Quality-by-Design pharmaceutical innovation in action, featuring tablet formulation analysis, molecular modelling, and digital quality systems supporting efficient drug development and manufacturing.

Find out how Quality-by-Design improves reliability and compliance in pharma and how you can maximise innovation through quality-based pharma development systems.

Nicole Dale

Reimagine AI-driven Drug Discovery with Pharma Superintelligence

Explore how AI-driven drug discovery is evolving through Pharmaceutical Superintelligence and what your organisation can do to keep up.

Nicole Dale

Real-Time Clinical Trials Are a Huge Competitive Advantage

Clinical researcher analysing live clinical trial dashboards and digital analytics, illustrating real-time clinical trials, continuous clinical trial data monitoring, adaptive trial management, and data-driven decision-making in pharmaceutical research.

Real-time clinical trials enable continuous data capture and faster decisions, improving how data is used in clinical trials. Here is what pharma leaders need to know.

Nicole Dale

Operation TrialBlazer: Can the U.S. Reclaim Clinical Trial Leadership?

Operation TrialBlazer aims to reshape U.S. clinical trials by combining FDA regulatory innovation, digital technologies, and modern trial strategies to reclaim global leadership in pharmaceutical development.

Operation TrialBlazer aims to reignite U.S. clinical development by accelerating trials, modernising FDA oversight, and strengthening pharmaceutical innovation.